Omega Healthcare Investors, Inc (OHI) FinancialsOHIOmega Healthcare Investors, Inc

Evaluating the bottom line, Omega Healthcare Investors, Inc. maintains a gross margin of 95.07%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 58.87%, while the net margin is 115.67%. These profitability ratios, combined with a Return on Equity (ROE) of 16.23%, provide a clear picture of how effectively OHI converts its operational activities into shareholder value.

In the context of the broader market, OHI competes directly with industry leaders such as DOC and REG. With a market capitalization of $13.85B, it holds a leading position in the sector. When comparing efficiency, OHI's gross margin of 95.07% stands against DOC's 57.02% and REG's 44.44%. Such benchmarking helps identify whether Omega Healthcare Investors, Inc. is trading at a premium or discount relative to its financial performance.

OHI has shown consistent revenue growth, with Q2 2026 revenues of $328.25 million, a 16.5% year-over-year increase. The gross margin remains high at 95.07%, indicating strong profitability.